Member LoginMember Login - User registration - Setup as front page - Add to favorites - Sitemap Abbott Labs tops Q1 expectations, raises low end of 2024 guidance range !

Abbott Labs tops Q1 expectations, raises low end of 2024 guidance range

Time:2024-05-01 08:45:08 source:Stellar Spectacle news portal

ABBOTT PARK, Illinois (AP) — Abbott Laboratories reported a first-quarter profit of $1.23 billion Wednesday.

The company, based in Abbott Park, Illinois, posted net income of 70 cents per share. Earnings, adjusted for one-time gains and costs, were 98 cents per share.

The results surpassed Wall Street expectations by 2 cents, according to Zacks Investment Research.

The maker of infant formula, medical devices and drugs posted revenue of $9.96 billion in the period, also beating analyst forecasts of $9.85 billion.

Abbott raised the low end of its full-year earnings forecast by five cents. It now expects earnings in the range of $4.55 to $4.70 per share.

Abbott shares, up 10% this year, fell more than 3% Wednesday.

_____

Elements of this story were generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ABT at https://www.zacks.com/ap/ABT

Related information
  • Scotland Yard to pay 'five
  • Xi Returns to China After China
  • Xi Extends Spring Festival Greetings to All Chinese
  • Protein markers tied to chemotherapy success
  • Finnish hacker imprisoned for accessing thousands of psychotherapy records and demanding ransoms
  • Xi Congratulates Lula on Inauguration as Brazilian President
  • Xi Stresses Systematic Protection of Intangible Cultural Heritage
  • 3 dead, 10 injured in fire at south China nursing home
Recommended content
  • Long flu season winds down in US
  • Chinese Vice Premier Stresses Need to Ensure Smooth Transition of COVID
  • French companies to step up investment in China
  • Xinhua Headlines
  • A Yellowstone trip that ended with a man being arrested for kicking a bison
  • Chinese Vice Premier Stresses Need to Ensure Smooth Transition of COVID